Key statistics
On Thursday, PTC Therapeutics Inc (PTCT:NSQ) closed at 36.16, -11.13% below its 52-week high of 40.69, set on May 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 36.36 |
---|---|
High | 37.09 |
Low | 35.94 |
Bid | 34.02 |
Offer | 36.20 |
Previous close | 35.48 |
Average volume | 543.94k |
---|---|
Shares outstanding | 76.92m |
Free float | 75.12m |
P/E (TTM) | -- |
Market cap | 2.73bn USD |
EPS (TTM) | -6.32 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PTC Therapeutics to Participate at Upcoming Investor Conferences
- PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
- PTC Therapeutics Announces Sepiapterin NDA Submission to FDA
- PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results
- CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review
More ▼